LENZ Therapeutics (LENZ) Other Non-Current Assets (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Other Non-Current Assets data on file, last reported at $2.5 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets rose 75.46% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 75.46% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 81.76% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $2.5 million, down from $2.5 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for LENZ reached as high as $2.5 million in Q4 2025 and fell as low as $21000.0 in Q4 2023.
• Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $1.5 million in 2024.
• Across the five-year window, Other Non-Current Assets surged 15500.0% in 2022 and plunged 98.78% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $1.3 million in 2022, then slumped by 98.37% to $21000.0 in 2023, then soared by 6557.14% to $1.4 million in 2024, then surged by 81.76% to $2.5 million in 2025, then fell by 3.46% to $2.5 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.5 million in Q1 2026, $2.5 million in Q4 2025, and $1.6 million in Q3 2025.